Skip to content

Study · Animal study (in vivo) · mouse · 1984

1 result

Enhancement of natural killer cell activity in mice by treatment with a thymic factor.

Bistoni F, Baccarini M, Puccetti P, Marconi P, Garaci E

Cancer immunology, immunotherapy : CII1 Jan 1984Cited by 12 (Europe PMC)

PMID6563944 (opens in a new tab)PMCIDPMC11039141 (opens in a new tab)DOI10.1007/bf00205497 (opens in a new tab)PepBankPUB-06563944
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Activity measurement

    In mice, thymosin alpha‑1 also increased natural killer cell activity, as thymostimulin did.

    In plain wordsIn mice, thymosin alpha‑1 raised natural killer cell activity, as thymostimulin did.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseNatural killer cell activity
    Study

    mousen: not reported in source

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    The effect was not limited to TP-1 treatment but was also observed on administration of another thymic factor (thymosin alpha 1).
    1 context sentence
    Summary · context
    The administration of a thymic factor, thymostimulin (TP-1), to mice resulted in considerable augmentation of natural killer (NK) cell activity as measured in a short-term assay against 51Cr-labeled YAC-1 target cells.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.